Dr Penny Sheehan

speaker

716 appearances 5 recordings 1 series first heard Jun 2026 last heard 20 Jul

Dr Penny Sheehan’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 5 in all, peaking in Jul 2026 with 3.

Appearances

newest first · ▶ plays the moment

Talking O&G - a RANZCOG Podcast · E21. Unpacking RANZCOG’s Intrapartum Fetal Surveillance Clinical Guideline (audio) · 5 Jun 2026 podcast

Fetal sepsis is so significant because all neot neatologists will tell you that for uh two neonates born at the same gestation, but one with sepsis and one without, the one with sepsis will definitely do worse.

So if you think that, if you have any suspicion that the fetus is mounting an inflammatory response, um you must expedite delivery.

And that's partly what the guideline says to always consider sepsis.

Sepsis, both maternal and fetal.

You know, expedite delivery if there's any suggestion that the the fetus does have sepsis.

And of course, fetal blood sampling, scalp electrodes may be contraindicated.

Well the fetal blood sampling is definitely contraindicated, but the scalp electrodes may also be contraindicated if again you suspect that sepsis is present.

Yeah, so the guideline we spent quite a bit of time discussing um tocolysis as well and prolonged decelerations over ninety seconds and up to five minutes can certainly be associated with fetal compromise and require action as listed in the guideline.

Excessive uterine activity is present, abnormal fetal heart rate patterns.

Um you can consider tocholytic therapy, provided there are no contraindications, and very important to consider always um is are there any contraindications such as suspected abruption, um, suspected uterine rupture, maternal medical conditions, allergies, fluid overload, any other reasons not to give

um tocolysis of course, um, it shouldn't be used.

But it is definitely worth considering, especially in the presence of excessive uterine activity.

We couldn't make a recommendation on the m safest drug.

The evidence is lacking.

So we think it's most important that a service puts together their own recommendation, settles on atokolytic, and includes a guideline for that so that the whole team knows what to do and can easily access it.

Yeah, I thought it was really interesting to include this.

Thousands of years ago, when I was a trainee, we used to do the vaginal examination and always look at the CTG that through the VE and often comment afterwards, you know, oh look, there was um good exhortation.

But it was never done in a kind of formalized way.

It was just part of our overall assessment.

So the suggestion here is that services might.

Showing 661–680 of 716 · page 34 of 36